**Core Concept:** Cervarix is a human papillomavirus (HPV) vaccine targeting high-risk types of HPV, which is responsible for causing cervical cancer and other genital warts. HPV is a group of more than 150 related viruses; however, Cervarix is designed to protect against 2 HPV types: HPV 16 and HPV 18.

**Why the Correct Answer is Right:** Cervarix, developed by GlaxoSmithKline, is a non-live, virus-like particle (VLP) vaccine. VLP mimics the structure of the virus but does not contain live HPV genetic material. HPV 16 and HPV 18 cause approximately 70% of cervical cancer cases globally. Vaccination against these two strains is crucial in preventing cervical cancer progression and related complications.

**Why Each Wrong Option is Incorrect:**

A. HPV 6 and HPV 11: These strains cause most genital warts but are not considered high-risk types for cervical cancer development. Cervarix primarily focuses on HPV 16 and 18.
B. HPV 31 and HPV 45: These strains are also high-risk types, but Cervarix does not target them.
C. HPV 39, 52, and 58: These strains are also considered high-risk types, but Cervarix does not protect against them.
D. HPV 68: HPV 68 is not targeted by Cervarix, as it focuses on high-risk types only.

**Clinical Pearl:** It is essential for healthcare professionals to accurately educate patients and parents about vaccine indications, contraindications, and the specific HPV strains targeted by each vaccine to ensure informed decision-making regarding HPV vaccination. This knowledge is crucial for preventing HPV-related diseases and reducing cervical cancer incidence.